A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines
Clinical trial NCT05074459 · COMPLETED
Trial details
- NCT number
- NCT05074459
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2022-07-18
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.